STEMCELL Technologies Inc., United Kingdom
Adam Hirst completed his Ph.D. under the supervision of Prof. Peter Andrews at the University of Sheffield. The main focus of his work was on the genetic stability of human pluripotent stem cells (hPSCs) and the impact cytogenetic changes have on downstream applications. Following his Ph.D. Adam worked as a Post-Doctoral Fellow at the University of Nottingham using hPSCs as well as porcine embryos to elucidate the mechanisms underlying primordial germ cell specification. Adam is currently a Senior Scientist in the Pluripotent Stem Cell Biology team at STEMCELL Technologies Inc. where he has been developing novel products to help advance the hPSC field. He has worked on a number of products including eTeSR™ a novel hPSC medium specifically developed to support single-cell passaging, CloneR™2, a supplements to improve the cloning efficiency of hPSCs, and the hPSC Genetic Analysis Kit, a qPCR based detection method for identifying karyotypic abnormalities.
Wednesday, July 10, 2024
12:25 PM – 1:00 PM CEST